ReviewFrontiers in oncology2014
Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine.
Donna M Graham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it